secwatch.observer — SEC 8-K summary
======================================

Issuer:     HilleVax, Inc. (—)
CIK:        0001888012
Form:       8-K
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0000950170-24-115027
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

HilleVax cuts 15 employees (25% of workforce) to reduce costs; exploring strategic alternatives
--------------------------------------------------------------------------------

- Workforce reduction of approximately 15 employees (~25% of total workforce).
- Estimated charges of ~$1.3M for severance, benefits and termination costs, expected in Q4 2024.
- Company exploring continued development of norovirus vaccine candidates and business development/strategic alternatives.
- Action aims to reduce operating expenses amid uncertainty over lead candidate HIL-214.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888012/000095017024115027/0000950170-24-115027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888012/000095017024115027/hlvx-20241015.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-115027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer